IGMS: IGM Bio O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
IgM antitanalari patentlari va FDA ning qat'iy nazorati tufayli kirishning yuqori to'siqlari IGM Biosciences, Inc. (IGMS) aksiyalarining narx dinamikasini boshqarmoqda. Og'irlikka ega PEG koeffitsiyenti ushbu jarayonlarni vizuallashtiradi, bunda 0.00 eng so'nggi baholash metrikasini belgilaydi. Murakkab proteinlar uchun ilmiy ekotizimning yaratilishi kompaniyaning mavqeini mustahkamlaydi, garchi R&D e'tiborining autoimmun patologiyalar sari keskin o'zgarishi tebranishlar va investitsiya risklarini oshirsa-da.
IGM Biosciences, Inc. (IGMS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati IGM Biosciences, Inc.|IGMS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi igmbio.com|IGMS - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar IGM Bio|IGMS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi IGM Biosciences|Kritik likvidlik igmbio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
IGMS - Kompaniyaning sof foydasi|Kelajakdagi foyda IGM Biosciences, Inc.|IGMS - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori igmbio.com|IGMS - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati IGM Bio|IGMS - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda IGM Biosciences|IGMS - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi igmbio.com|IGMS - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi IGM Biosciences, Inc.
Kompaniyaning umumiy tahlili:IGMS - IGM Biosciences Inc.
Portfelni boshqarish uchun biznes qiymatini foyda kengayish sur'atlariga nisbatan baholash juda muhimdir, bu esa P/E ko'rsatkichi bilan tushumlar o'sishi dinamikasini solishtirish orqali amalga oshiriladi. peg_co koeffitsiyentini tahlil qilish qadrsizlangan aktivlarni aniqlashga yordam bersa-da, IGM Biosciences, Inc. (IGMS) uchun ushbu metrika kompaniyaning tijorat mahsulotlari yo'qligi va tashqi moliyalashtirishga bog'liqligi sababli spekulyativ bo'lib qolmoqda.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Pharvaris Pharma PHVS|ABCL: PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati tourmalinebio.com TRML|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|Narx-foyda va o‘sish multiplikatori Pharming Group NV (PHAR)|Narx-foyda va o‘sish multiplikatori NKTR (Nektar)|UPB (Upstream Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|immunome.com - Narxning foydaga va o‘sish sur’atiga nisbati|Gossamer Bio - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati KalVista Pharma KALV|Septerna Corp (SEPN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Pieris Corp (PVLA)|Narxning foydaga va o‘sish sur’atiga nisbati Savara Inc.|rigel.com (RIGL) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori ANAB|Narx-foyda va o‘sish multiplikatori Astria Therapeutics Inc ATXS|PEG multiplikatori ENGN (enGene Bio)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati rapt.com (RAPT)|Aerovate - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda aclaristx.com|Kyverna Therapeutics, Inc. (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TLSA|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Ventyx Biosciences, Inc (VTYX)|PEG multiplikatori THTX|AVTX - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Eledon Pharmaceuticals, Inc. ELDN|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Agenus, Inc. (AGEN)|CLYM: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ZURA (zurabio.com)|ATYR: PEG multiplikatori|ADAG - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati ImageneBio|O‘sishni hisobga olgan narx-foyda koeffitsiyenti STTK (Shattuck Therapeutics)|PEG multiplikatori EQ|Narx-foyda va o‘sish multiplikatori connectbiopharm.com CNTB|Immunic - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Atara Biotherapeutics, Inc. (ATRA)|InflaRx GmbH - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati X4 Pharmaceuticals Inc. XFOR|ACET: PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Celularity CELU|Narxning foydaga va o‘sish sur’atiga nisbati INmune Bio, Inc.|Narx-foyda va o‘sish multiplikatori barinthusbio.com (BRNS)|Narxning foydaga va o‘sish sur’atiga nisbati Kezar Life Sciences, Inc. (KZR)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati SAB Biotherapeutics Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Akari Therapeutics plc AKTX|ENLV (Enlivex Therapeutics Ltd) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Q32 Bio Corp - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti GOVX (geovax.com)|EDSA: PEG multiplikatori|iBio Inc (IBIO) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Carisma Therapeutics Inc|XTLB: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Bolt Biotherapeutics (BOLT)|Narx-foyda va o‘sish multiplikatori hcwbiologics.com HCWB|PEG multiplikatori APVO (Aptevo Therapeutics Inc.)|PEG multiplikatori aimimmuno.com AIM|ADTX: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti GRI (GRI Bio Corporation)|XRTX: PEG multiplikatori|HIND - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Revelation Biosciences, Inc.|Narx-foyda va o‘sish multiplikatori Indaptus Therapeutics Inc (INDP)|Narxning foydaga va o‘sish sur’atiga nisbati Scinai (SCNI)|Narx-foyda va o‘sish multiplikatori calcimedica.com CALI|Affimed N.V. - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Allakos Inc ALLK|HOOK - Narxning foydaga va o‘sish sur’atiga nisbati|ITOS (iTeos Therapeutics Inc) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|OCEA: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda TC BioPharm Ltd (TCBP)|THRD (Third Harmonic Bio) - PEG multiplikatori
